Candel Therapeutics (NASDAQ:CADL) priced an underwritten public offering of 10M shares at $6.00 per share and pre-funded ...

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...

Holding Company has entered into a definitive agreement with certain institutional investors for the purchase and sale of an ...

Universe Pharmaceuticals shares are trading lower by 58% during Monday's session. The company announced a registered direct ...

In a significant development, Lichen China Limited recently announced a definitive agreement with several investors for the purchase and sale of 15,000,000 of its Class A ordinary shares. These shares ...

The revenue number in paragraph 5 was erroneously attributed to OpenReel instead of Banzai On Tuesday, Banzai International, ...

BTC Digital shares are trading lower by 24.6% during Friday's session. The company announced a $20 million public offering.

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of ...

The aggregate gross proceeds to the Company of this offering are expected to be approximately $2.70 million. The transaction is expected to close on or about December 13, 2024, subject to the ...

All of the shares and pre-funded warrants in the offering are to be sold by Revolution Medicines. In addition, Revolution Medicines has granted the underwriters a 30-day option to purchase up to an ...